Determination of metabolites of a novel platinum anticancer drug JM216 in human plasma ultrafiltrates

J Pharm Biomed Anal. 1995 Nov;13(12):1493-8. doi: 10.1016/0731-7085(95)01571-x.

Abstract

The present study describes the application of on-line liquid chromatography-electrospray ionisation in conjunction with a high resolution magnetic sector mass spectrometer to identify metabolites of a platinum(IV) anticancer drug JM216 [bis(acetato)amminedichloro(cyclohexylamine)platinum(IV)] in human plasma. Four metabolites were identified following incubation of JM216 in human plasma: JM118 [amminedichlorocyclohexylamineplatinum(II)], a platinum(II) complex; JM383 [bis(acetato)amminedihydroxo(cyclohexylamine)platinum(IV)]; JM518 [bis(acetato)amminechloro(cyclohexylamine)hydroxoplatinum (IV)] and its isomer JM559. The platinum complexes mass spectra were dominated by the natriated [M + Na]+ ion. Elemental compositions of these natriated ions were confirmed by accurate mass measurement on a magnetic sector mass spectrometer in the course of LC/MS analysis. This study demonstrates the capability of direct LC-ESI/MS with accurate mass measurement for analysis of platinum complexes in biological samples. Our results suggest that LC-ESI/MS is a powerful technique for structure elucidation of novel metabolites, and could make valuable contributions to drug metabolism research.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / blood*
  • Antineoplastic Agents / pharmacokinetics*
  • Biotransformation
  • Chromatography, Liquid
  • Flame Ionization
  • Humans
  • Isomerism
  • Mass Spectrometry
  • Organoplatinum Compounds / blood*
  • Organoplatinum Compounds / pharmacokinetics*
  • Platinum / blood
  • Polyethylene Glycols / analysis
  • Ultrafiltration

Substances

  • Antineoplastic Agents
  • Organoplatinum Compounds
  • Polyethylene Glycols
  • Platinum
  • satraplatin